Ultragenyx Pharmaceutical Inc. (RARE)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Alkeon Capital Management

Panayotis Takis Sparaggis

2,241,832 $107,204,406 +16% 0.23%
2. 2,126,306 $101,679,953 +213% 4.59%
3.
Rock Springs Capital Management

Kris Jenner, Gordon Bussard, Graham Mcphail

1,754,038 $83,878,097 +19% 2.06%
4.
Marshall Wace LLP

Paul Marshall And Ian Wace

1,489,486 $71,227,220 +59% 0.12%
5.
Baker Bros. Advisors

Julian Baker And Felix Baker

1,466,547 $70,130,278 +8% 0.79%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$43.63 5,000 Officer, Director 472,479 2019-09-11 Filing
$52.96 1,647 Officer, Director 2,559,741 2017-08-28 Filing
$52.40 5,853 Officer, Director 2,558,094 2017-08-28 Filing
$21.00 175,000 Large Shareholder, Other 3,260,240 2014-01-31 Filing
$21.00 4,500 Officer 84,255 2014-01-30 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$49.93 11,509 252,823 2024-03-11 Filing
$50.88 7,500 14,860 2024-03-07 Filing
$50.85 2,145 22,360 2024-03-07 Filing
$50.89 2,550 24,505 2024-03-07 Filing
$53.76 3,756 67,340 2024-03-01 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 8,673,432 $414,763,518 0%
2. 6,887,086 $329,340,453 5.14%
3. 5,238,400 $250,500,292 0%
4. 4,415,029 $211,126,686 0.03%
5. 4,118,008 $196,923,143 0.59%
News See All